StemCell Institute Inc. (TYO:7096)

Japan · Delayed Price · Currency is JPY

766.00

-2.00 (-0.26%)

Jul 16, 2026, 9:55 AM JST

-19.87% (1Y)

Market Cap	7.87B -26.5%
Revenue (ttm)	2.81B +4.9%
Net Income	155.00M -59.7%
EPS	15.35 -59.2%
Shares Out	10.25M
PE Ratio	50.04
Forward PE	70.46
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	766.00
Previous Close	768.00
Day's Range	766.00 - 766.00
52-Week Range	627.00 - 1,245.00
Beta	0.59
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 7, 2026

About StemCell Institute

StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of new cell-based treatments, and pharmaceuticals and medical devices. It also engages in cell contract management and transportation business; extraction, purification, processing, storage, testing and sales of biological tissue-derived components; and medical facility operation and management business. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. ... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 117

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 7096

Full Company Profile

Financial Performance

In fiscal year 2026, StemCell Institute's revenue was 2.81 billion, an increase of 4.93% compared to the previous year's 2.68 billion. Earnings were 155.00 million, a decrease of -59.74%.

Financial Statements